Listed by the USPTO as VARADARAJ, ARCHANA
Tech Center 1600 • Art Units: 1618 1636 1653 1654 1658 1675
This examiner grants 80% of resolved cases
VARADARAJ, ARCHANA has resolved 5 cases in technology center 1600 and art unit 1618. The allowance rate is 80.0%, and the median time to allowance is 1273 days. Interviews are associated with a 33.3% lift in the allowance rate. Because the resolved-case record is very limited, these figures should be treated as a narrow profile of the available cases.
The United States of America, as represented by the Secretary, Department of Health and Human Services, Hbc Immunology Inc., and Fujifilm Corporation are the listed leading companies. GOODWIN PROCTER LLP, MORRISON & FOERSTER LLP, and SUGHRUE MION, PLLC are the listed leading firms. Practitioners can use the listed participants for docket research while recognizing the limited basis for generalization.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18468937 | METHOD FOR PRODUCING AMINO ACID OR PEPTIDE, PROTECTIVE GROUP-FORMING REAGENT, AND COMPOUND | Non-Final OA | FUJIFILM Corporation |
| 18541815 | BICYCLIC PEPTIDYL INHIBITOR OF TUMOR NECROSIS FACTOR-ALPHA | Non-Final OA | Ohio State Innovation Foundation |
| 18690563 | Prodrugs of Antibiotic Teixobactin | Non-Final OA | The Regents of the University of California |
| 18707072 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PAIN, COMPRISING GR82334 AS ACTIVE INGREDIENT | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18223327 | METHODS FOR TREATING GRAFT-VERSUS-HOST DISEASE USING GLP-2 AGONISTS AND ANALOGUES THEREOF | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18460519 | FLUORINATED FIBERS FOR MULTIMODAL 1H AND 19F MRI, ULTRASOUND, FLUORESCENCE DETECTION AND CONFORMATIONAL AND TEMPERATURE DETECTION BY 19F MRS | Non-Final OA | New York University |
| 18331331 | HIDDEN ANTIBIOTICS IN THE HUMAN PROTEOME | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18253146 | EXTREMELY FAST SOLID PHASE SYNTHESIS | Non-Final OA | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.0% of resolved applications examined by Archana Varadaraj were allowed (5 resolved cases), compared with 33.1% across Art Unit 1618 over the last five years.
This examiner's interview lift is +33.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Archana Varadaraj took 1,273 days on average from filing to allowance.
Archana Varadaraj examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
